Assessing the Prevalance of Immunization Status, Complications and Outcomes in Children with MMR (MMR,mumps,Rubella ):A cross sectional study
DOI:
https://doi.org/10.63682/jns.v14i26S.9329Keywords:
Immunization, Outcome, Mumps, Measles, Rubella, MMRAbstract
Background: The MMR vaccine is a combination vaccine that protects against measles, mumps and rubella. Mumps is a viral disease caused by the mumps virus, belonging to the family Paramyxoviridae and is characterized by swelling of the parotid glands and can lead to complications such as orchitis and meningitis. Measles is another infectious viral exanthema, caused by Morbilivirus belonging to the family Paramyxoviridae. The MMR vaccine is a combination vaccine that protects against two highly contagious and potentially serious viral diseases.
Objective: To assess the immunization Status, complications and outcome in Children with MMR.
Methodology: This cross sectional study was conducted at Dow university hospital. The study duration was of 1 year from January 2024 to December 2024. A total of 200 patients of either sex from the ages of 3 months to 13 years who presented with measles, mumps, rubella or with its complications were included. Detailed history and physical examination was done and findings entered in a proforma that had been prepared after thorough research of literature. Immunization status of the patients was checked by examining the National Expanded Program on Immunization (EPI) card where available or parental enquiry if EPI card was not available. All the relevant investigations like complete blood count, serum electrolytes and X- ray chest were carried out besides history and clinical examination. Cerebrospinal fluid examination was done where needed. Results: A total of 200 patients were admitted during the study period with measles, mumps, rubella or its complications. Male were 170 (85.3%) of and females accounted for 30 (14.7%). The vaccination status of the patients revealed that 113 (56.76%) had received complete vaccination against MMR, while 47 (23.24%) were unvaccinated and 40 (20%) were partially vaccinated. The most common complication was pneumonia affecting 90 (45%) patients, followed by gastroenteritis in 42 (22%) ,bleeding problems 8 (4%) and rarely orchitis 4 (2%) in patients. Notably, 56 (28%) patients had no complications
Downloads
References
Turaiche M, Feciche B, Gluhovschi A, Bratosin F, Bogdan I, Bota AV, Grigoras ML, Gurban CV, Cerbu B, Toma AO. Biological Profile and Clinical Features as Determinants for Prolonged Hospitalization in Adult Patients with MMR: A Monocentric Study in Western Romania. Pathogens. 2022;11:1018.
Ameer M, Aziz S, Ehsan S, Kulsoom U. Frequency of Immunization Status, Complications and Outcome in Children Admitted with MMR in Public and Private Sector Hospitals of Karachi. Annals Abbasi Shaheed Hospital Karachi Med Dental Coll. 2018;23(1):21- 28.
Jain R, Aulakh R. MMR-Associated CNS Complications: A Review. J Child Sci. 2022;12:172-181.
Aurangzeb B, Fatmee A, Waris R, Haider N, Berjees A, Raza SH. Risk factors for mortality among admitted children with complications of MMR in Pakistan: An observational study. J Pak Med Assoc. 2021;71(2A):497-501.
Bester JC. MMR and MMR vaccination: a review. JAMA Pediatr. 2016;170:1209-15.
Javed T, Bibi A, Chishti AL, Siddique K. Morbidity and Mortality Pattern of Hospitalized Children with MMR at Mayo Hospital, Lahore. Ann King Edward Med Uni. 2024;20:55-60.
Kazi AN. MMR epidemics exposes inadequate vaccination coverage in Pakistan. BMJ 2013;346: f245. [DOI:10.1136/bmj.f245].
Khan AW, Ghani A, Malik L. Pandora box opened- MMR unleashed in Pakistan. JPMA 2023;63:1328.
Gaafar T, Moshni E, Lievano F. The challenge of achieving MMRe limination in the eastern Mediterranean region by 2021. J Infect Dis 2003;187:164-71.
Rafi S, Shah IA, Rao MH, Billoo AG. Expanded Program for Immunisation in Karachi. J Pak Med Assoc 2020; 45:34-7.
Patel MK, Dobo MG, Strebel PM, Dabbagh A, Mulders MN, Okwo-bele M et al. Progress to- wards regional MMR elimination-Worldwide, 2000-2015. MMWR Morb Mortal Wkly Rep 2019;65:1228-33. 0
Sheikh S, Ali A, Zaidi AKM, Agha A, Khowaja A, Allana S et al. MMR Susceptibility in Children in Karachi, Pakistan. Vaccine 2019;29: 3419-23.
World Health Organization Elimination of MMR in the Republic of Korea 2001-2006. Wkly Epidemiol Rec 2017;14:118-24.
De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G. Progress towards MMR eradica- tion in the region of Americas. J Infect Dis 2013;187:S102-S10.
Orenstein W, Seib K. Mounting a Good Offence against MMR. NEJM 2014;371:1661-3.
Tulloch J. Integrated approach to child health in developing countries. Lancet 2019;354:S16-20.
Shrivastava SR, Shrivastava PS, Ramasamy J. MMR in India: challenges and recent develop- ments. Infect Ecol Epidemiol 2015;5:27784.
Khan T, Qazi J. MMR outbreaks in Pakistan: causes of the tragedy and future implications. Epidemiol Rep 2018;2:1. Available from: http:// www.hoajonline.com/epidemiolrep/2054- 9911/2/1.
Zahidie A, Wasim S, Fatmi Z. Vaccine effective- ness and Risk Factors Associated with MMR among children presenting to the Hospitals of Karachi, Pakistan. J Coll Physicians Surg Pak 2017;24:882-8.
Younas S, Rehman HU, Saleem A, Walayat B, Naveed SA, Usman B et al. MMR virus out- break in district Karak, KP Pakistan. JEZS 2017;5:1655-61.
Davoodian P, Atashabparwar A, Dadvand H, Hosseinpour M, Daryanavard A, Safari R et al. A report of outbreak of MMR on the southern coast of Iran from 2009 to 2015. Electron P,hysician 2017;9: 3997-4002. [DOI:10.19082/ 3997].
Faneye AO, Adeniji JA, Olusola BA, Motayo BO, Akintunde GB. MMR Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria. Viral Immunology 2017;28:304-8.
Leuridan E, Hens N, Hutse V, Leven M, Aerts M, Van Damme P. Early waning of maternal MMR antibodies in era of MMR elimination: a longi- tudinal study. BMJ 20109;340:c1626
Waaijenborg S, Hahne S, Mollema L, Smits GP, Berbers GA, van der Klis FR et al. Waning of ma- ternal antibodies against MMR, rubella and varicella in communities with contrasting vaccina- tion coverage. J Infect Dis 2018;208:10-60. [DOI: 10.1093/infdis/jit143].
Duke T, Mgone CS. MMR: not just a viral exan- them. Lancet 2003;361:763-73.
Rashid MA, Afridi MI, Rehman MA. Frequency of complications in MMR patients at Peshawar. Gomal J Med Sci 2016; 14:112-6. Available from: http://www.gjms.com.pk/ojs/index.php/gjms/article/ view/1402. Accessed on January 21, 2018.31.
Ledogar RJ, Fleming J, Anderson N. Knowledge synthesis of benefits and adverse effects of MMR vaccination: the Lasbela balance sheet. BMC Int Health Hum Rights 2019;9:S6. [DOI:10.1186/1472_698x_9_S1_S6].
Sheikh S, Ali A, Zaidi AK, Agha A, Khowaja A, Allana S, et al. MMR susceptibility in children in Karachi, Pakistan. Vaccine 2021;29:3419-23.[DOI: 10.1016/j.vaccine.2011.02.087].
Mushtaq A, Naz S, Bari A. Masood T. MMR in Children: still a problem today. PJMHS 2022;6: 755-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
